Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a seven-year period

Endocrine Journal

Volumn 59, Issue 10, 2012, Pages 931-939

  Bleicken, Benjamin ^a   Ventz, Manfred ^a   Hinz, Andreas ^b   Quinkler, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Congenital adrenal hyperplasia; Dexamethasone; Hydrocortisone; Prednisolone; Short Form 12 (SF 12)

Indexed keywords

DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; PREDNISOLONE; STEROID 21 MONOOXYGENASE;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LONGITUDINAL STUDY; OUTPATIENT; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SHORT FORM 12; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LONGITUDINAL STUDIES; MIDDLE AGED; PREDNISOLONE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84869219910     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0183     Document Type: Article

References (31)

1. Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. Lancet 365(9477):2125-2136.
2. Bachelot A, Chakthoura Z, Rouxel A, Dulon J, Touraine P (2008) Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults. Horm Res 69(4):203-211.
3. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC (2010) Congenital adrenal hyperplasia due to steroid 21-hy droxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95(9):4133-4160
4. Koetz K, Kienitz T, Quinkler M (2010) Management of steroid replacement in adrenal insufficiency. Minerva Endocrinol 35(2):61-72.
5. Quinkler M, Hahner S (2012) What is the best longterm management strategy for patients with primary adrenal insufficiency? Clin Endocrinol (Oxf) 76(1):21-25.
6. Auchus RJ (2010) Congenital adrenal hyperplasia in adults. Curr Opin Endocrinol Diabetes Obes 17(3):210-216
7. Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B, Quinkler M (2010) Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 72(3):297-304.
8. Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W, Allolio B (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 92(10):3912-3922.
9. Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B, Quinkler M (2008) Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur J Endocrinol 159(6):811-817.
10. Lovas K, Loge JH, Husebye ES (2002) Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56(5):581-588.
11. Johannsen TH, Ripa CP, Reinisch JM, Schwartz M, Mortensen EL, Main KM (2006) Impaired cognitive function in women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 91(4):1376-1381.
12. Kuhnle U, Bullinger M, Schwarz HP (1995) The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur J Pediatr 154(9):708-716.
13. Jaaskelainen, Voutilainen R (2000) Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr 89(2):183-187
14. Johannsen TH, Ripa CP, Mortensen EL, Main KM (2006) Quality of life in 70 women with disorders of sex development. Eur J Endocrinol 155(6):877-885.
15. Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ (2010) Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 95(11):5110-5121.
16. Reisch N, Hahner S, Bleicken B, Flade L, Pedrosa GF, Loeffler M, Ventz M, Hinz A, Beuschlein F, Allolio B, Reincke M, Quinkler M (2011) Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin Endocrinol (Oxf) 74(2):166-173.
17. Nermoen I, Husebye ES, Svartberg J, Lovas K (2010) Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur J Endocrinol 163(3):453-459.
18. Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Malunowicz EM, Grzechocinska B, Kaminski P, Bablok L, Przedlacki J, Bar-Andziak E (2010) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency-management in adults. Endokrynol Pol 61(1):142-155.
19. Caldato MC, Fernandes VT, Kater CE (2004) Oneyear clinical evaluation of single morning dose prednisolone therapy for 21-hydroxylase deficiency. Arq Bras Endocrinol Metabol 48(5):705-712.
20. Rivkees SA, Crawford JD (2000) Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 106(4):767-773.
21. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324(7351):1417.
22. Nemeth G (2006) Health related quality of life outcome instruments. Eur Spine J 15 Suppl 1:S44-S51.
23. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361-370
24. Hinz A, Brahler E (2011) Normative values for the hospital anxiety and depression scale (HADS) in the general German population. J Psychosom Res 71(2):74-78.
25. Koetz KR, Ventz M, Diederich S, Quinkler M (2012) Bone Mineral Density Is Not Significantly Reduced in Adult Patients on Low-Dose Glucocorticoid Replacement Therapy. J Clin Endocrinol Metab 97(1):85-92.
26. Lovas K, Gjesdal CG, Christensen M, Wolff AB, Almas B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES (2009) Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol 160(6):993-1002.
27. Reisch N, Arlt W, Krone N (2011) Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 76(2):73-85.
28. Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, Thompson CJ, Agha A (2011) Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients. Clin Endocrinol (Oxf) 75(4):505-513.
29. Bachelot A, Plu-Bureau, Thibaud E, Laborde K, Pinto G, Samara D, Nihoul-Fekete C, Kuttenn F, Polak M, Touraine P (2007) Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 67(6):268-276.
30. Hagenfeldt K, Martin RE, Ringertz H, Helleday J, Carlstrom K (2000) Bone mass and body composition of adult women with congenital virilizing 21-hydrox ylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol 143(5):667-671.
31. Huang IC, Frangakis C, Wu AW (2006) The relationship of excess body weight and health-related quality of life: evidence from a population study in Taiwan. Int J Obes (Lond) 30(8):1250-1259.